Total Funding
47
27
Total FundingPost-IPO Equity raised
Growth Score
1 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
157782
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
Robert Horvitz: Scientific Co-FounderPast Role: National Institutes of Health, Member
Yi Zhang: Scientific Co-FounderPast Role: UNC Kenan-Flagler Business School, Professor of Biochemistry and Biophysics
About the Company
Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors.
Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will
produce important, novel, molecularly targeted drugs of the future.
